Day: August 9, 2024

KALMAR CORPORATION, MANAGERS’ TRANSACTIONS, 9 AUGUST 2024 AT 3:00 PM EEST Kalmar Corporation, Managers’ Transactions: Niiranen, Sami ____________________________________________Person subject to the notification requirementName: Sami NiiranenPosition: Chief Executive OfficerIssuer: Kalmar OyjLEI: 636700Z25ZQXLMZ3CY73Notification type: INITIAL NOTIFICATIONReference number: 73945/5/4 ____________________________________________Transaction date: 2024-08-09Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000571054Nature of transaction: ACQUISITION Transaction details(1): Volume: 5000 Unit price: 25.9082 EUR Aggregated transactions (1):Volume: 5000 Volume weighted average price: 25.9082 EUR Additional information:Carina Geber-Teir, SVP, IR, Marketing & Communications, tel. +358 40 502 4697 Camilla Maikola, Director,...

The Bisbee Plan by LGI Homes The three-bedroom, two-bathroom Bisbee features a wonderful open-concept floor plan and a wonderful covered, outdoor patio. ALBUQUERQUE, N.M., Aug. 09, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the opening of its latest communities, Villa De Marcos Gabriel and Legacy at Sierra Vista, in the Albuquerque market. These exceptional new neighborhoods offer stunning new construction homes, with prices starting in the low $300s. Villa De Marcos Gabriel is ideally situated in Stinson Tower, providing residents with quick and easy access to a wide array of big-city amenities. This charming community is conveniently located near numerous employers, parks, recreation centers and other local attractions. Legacy at Sierra Vista offers a serene living environment paired...

PALM BEACH GARDENS, Fla., Aug. 09, 2024 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2025 second quarter results on Wednesday, August 21, 2024, at 9:00 a.m. ET. Dycom will issue a press release reporting its results earlier that morning. Interested parties may participate in the question and answer session of the conference call by registering at https://register.vevent.com/register/BI792f883035104fca9ba48d0d4da25061. Upon registration, participants will receive a dial-in number and unique PIN to access the call. Participants are encouraged to join approximately ten minutes prior to the scheduled start time. For all other attendees, a live listen-only audio webcast of the call, including an accompanying slide presentation, can be accessed directly at https://edge.media-server.com/mmc/p/rk4t4eoj....

Conference call will be held today, Friday, August 9 at 9:00 am ET Carmel, Ind., Aug. 09, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the second quarter period ended June 30, 2024. Recent Operational Highlights Expanded total covered lives to approximately 22.5 million covered lives compared to 4.5 million covered lives as of May 1, 2023. Recent medical policy coverages include: BCBS licensee in Florida covering over 6 million lives. BCBS licensee in North Dakota covering over 310,000 people. BCBS plan in the mid-Atlantic region, providing coverage for approximately 7 million covered lives. Medical Policy with a BCBS...

TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB,H, FC.DB.I, FC.DB.J ,FC.DB. K and FC.DB.L) today released its financial statements for the six months ended June 30, 2024. NET INCOMEFor the three months ended June 30, 2024, net income increased by 0.1 % to $8,533,772 as compared to $8,522,355 for the same period in 2023. Net income for the six months ended June 30, 2024 decreased by 0.8% to $17,103,556, as compared to $17,234,251 reported for the same period in 2023. EARNINGS PER SHAREBasic weighted average earnings per share for the three months ended June 30, 2024 was $0.247 (2023 – $0.245). Basic weighted average earnings per share for the six months ended June 30, 2024 was $0.496 (2023 – $0.500). PORTFOLIOThe Corporation’s Investment Portfolio increased...

Companies will present interactive, no-code, turnkey, robotic machine tending demos in booth #236520 and booth #338319 at the 2024 International Manufacturing Technology Show (IMTS) in Chicago, Illinois (USA) INDIANAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC), a premier CNC machine and controls industrial technology company, and Kawasaki Robotics (USA), Inc., a leading manufacturer of industrial robotics and automation systems, announced today the formation of a strategic collaboration aimed at enhancing innovation and delivering industrial-grade robotic CNC machine solutions to their customers. The collaboration will leverage the strengths of both companies, combining 50+ years of Hurco’s CNC machine and controls innovation for short-run manufacturing operations with 50+ years of Kawasaki’s...

– Tesla Membership: Boasts 26% year-over-year growth – New Paid Members: Increase over 225k in Fiscal Year 2025 and an impressive 64K in July 2024 – Total Membership: Grew 23% year-over-year – B2B Pipeline: Expands to 63, including four signed partnerships to be announced upon launch LOS ANGELES, Aug. 09, 2024 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment and technology platform, announced today an update for certain of its July 2024 and fiscal year ending March 31, 2025 (“Fiscal Year 2025”) memberships metrics and its B2B pipeline. Brad Konkol, Head of Slacker Radio, commented, “We are pleased with our continued growth and extremely enthusiastic regarding the strategic vision of Slacker Radio and LiveOne. Our commitment to building strong B2B partnerships...

SAN CLEMENTE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 12 – 13, 2024. About Sofwave MedicalSofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), lifting lax skin in the arms, as well as the short-term improvement in the...

Initiated and Enrolling Patients into MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101 radio-immuno-therapeutic (RIT) Clinical Trial on Track to Initiate in Q4 2024 WILMETTE, Ill., Aug. 09, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, today announced second quarter 2024 financial results and summarized recent developments. Recent Developments MNPR-101 for Radiopharmaceutical Use MNPR-101 is a uPAR-targeting antibody being developed as a precision radiopharmaceutical for both imaging and treatment of various cancers. MNPR-101-Zr is a cancer imaging agent radiolabeled with Zirconium-89, a positron emission tomography (PET) imaging isotope. Preclinical...

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) — Urbana Corporation (TSX & CSE: URB & URB.A) Urbana Corporation announces today that it has filed its unaudited interim Financial Statements and Management’s Discussion and Analysis for the six-month period ended June 30, 2024 with the applicable Canadian securities regulators. PDF versions of the documents are available at www.urbanacorp.com and at www.sedarplus.ca. For further information contact: Elizabeth Naumovski Investor Relations (416) 595-9106 enaumovski@urbanacorp.com 150 KING ST. W., SUITE 1702, TORONTO, ONTARIO M5H 1J9   TEL: 416-595-9106 FAX: 416-862-2498 www.urbanacorp.com